Disease-free survival as a surrogate endpoint for overall survival in adjuvant trials of pancreatic cancer: a meta-analysis of 20 randomized controlled trials

被引：0
|
作者：
Run-Cong Nie
Xue-Bin Zou
Shu-Qiang Yuan
Ying-Bo Chen
Shi Chen
Yong-Ming Chen
Guo-Ming Chen
Xiao-Jiang Chen
Tian-Qi Luo
Shu-Man Li
Jin-Ling Duan
Yun Wang
Yuan-Fang Li
机构：
[1] Sun Yat-sen University Cancer Center,Department of Gastric Surgery
[2] State Key Laboratory of Oncology in South China,Department of Ultrasound, Sun Yat
[3] Collaborative Innovation Center for Cancer Medicine,sen University Cancer Center, State Key Laboratory of Oncology in South China
[4] Collaborative Innovation Center for Cancer Medicine,Department of Gastric Surgery, The 6th Affiliated Hospital
[5] Sun Yat-sen University,Department of Experimental Research (Cancer Institute)
[6] Sun Yat-sen University Cancer Center,Department of Hematologic Oncology, Sun Yat
[7] State Key Laboratory of Oncology in South China,sen University Cancer Center, State Key Laboratory of Oncology in South China
[8] Collaborative Innovation Center for Cancer Medicine,undefined
[9] Collaborative Innovation Center for Cancer Medicine,undefined
来源：
BMC Cancer | / 20卷
关键词：
Pancreatic cancer; Disease-free survival; Overall survival; Surrogate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
相关论文
共 50 条
  • [1] Disease-free survival as a surrogate endpoint for overall survival in adjuvant trials of pancreatic cancer: a meta-analysis of 20 randomized controlled trials
    Nie, Run-Cong
    Zou, Xue-Bin
    Yuan, Shu-Qiang
    Chen, Ying-Bo
    Chen, Shi
    Chen, Yong-Ming
    Chen, Guo-Ming
    Chen, Xiao-Jiang
    Luo, Tian-Qi
    Li, Shu-Man
    Duan, Jin-Ling
    Wang, Yun
    Li, Yuan-Fang
    BMC CANCER, 2020, 20 (01)
  • [2] Disease-free survival is not a surrogate endpoint for overall survival in adjuvant trials of pancreatic cancer: a systematic review of randomized trials
    Petrelli, Fausto
    Tomasello, Gianluca
    Ghidini, Michele
    Lonati, Veronica
    Passalacqua, Rodolfo
    Barni, Sandro
    HPB, 2017, 19 (11) : 944 - 950
  • [3] Disease-Free Survival as a Surrogate for Overall Survival in Adjuvant Trials of Gastric Cancer: A Meta-Analysis
    Oba, Koji
    Paoletti, Xavier
    Alberts, Steven
    Bang, Yung-Jue
    Benedetti, Jacqueline
    Bleiberg, Harry
    Catalano, Paul
    Lordick, Florian
    Michiels, Stefan
    Morita, Satoshi
    Ohashi, Yasuo
    Pignon, Jean-pierre
    Rougier, Philippe
    Sasako, Mitsuru
    Sakamoto, Junichi
    Sargent, Daniel
    Shitara, Kohei
    Cutsem, Eric Van
    Buyse, Marc
    Burzykowski, Tomasz
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (21): : 1600 - 1607
  • [4] Investigation of disease-free survival as a surrogate endpoint for survival in cancer clinical trials
    Chen, TT
    Simon, RM
    Korn, EL
    Anderson, SJ
    Lindblad, AS
    Wieand, HS
    Douglass, HO
    Fisher, B
    Hamilton, JM
    Friedman, MA
    COMMUNICATIONS IN STATISTICS-THEORY AND METHODS, 1998, 27 (06) : 1363 - 1378
  • [5] Progression-free survival as a surrogate endpoint for overall survival in modern ovarian cancer trials: a meta-analysis
    Sjoquist, Katrin M.
    Lord, Sarah J.
    Friedlander, Michael L.
    Simes, Robert John
    Marschner, Ian C.
    Lee, Chee Khoon
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2018, 10 : 1 - 16
  • [6] Surrogate endpoints for overall survival in randomized controlled trials evaluating adjuvant treatment for breast cancer: A meta-analysis
    Savina, M.
    Jacot, W.
    Mathoulin-Pelissier, S.
    Laghzali, Y.
    Bellera, C.
    Gourgou, S.
    ANNALS OF ONCOLOGY, 2017, 28
  • [7] Reevaluating Disease-Free Survival as an Endpoint vs Overall Survival in Stage III Adjuvant Colon Cancer Trials
    Yin, Jun
    Salem, Mohamed E.
    Dixon, Jesse G.
    Jin, Zhaohui
    Cohen, Romain
    DeGramont, Aimery
    Van Cutsem, Eric
    Taieb, Julien
    Alberts, Steven R.
    Wolmark, Norman
    Schmoll, Hans-Joachim
    Saltz, Leonard B.
    George, Thomas J.
    Goldberg, Richard R. M.
    Kerr, Rachel
    Lonardi, Sara
    Yoshino, Takayuki
    Yothers, Greg
    Grothey, Axel
    Andre, Thierry
    Shi, Qian
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2022, 114 (01): : 60 - 67
  • [8] META-ANALYSIS OF THE VALIDITY OF PROGRESSION-FREE SURVIVAL AS A SURROGATE ENDPOINT FOR OVERALL SURVIVAL IN METASTATIC COLORECTAL CANCER TRIALS
    Chirila, C.
    Odom, D. M.
    Devercelli, G.
    Khan, S.
    Sherif, B. N.
    Kaye, J. A.
    Molnar, I.
    Sherrill, B. H.
    ANNALS OF ONCOLOGY, 2010, 21 : 202 - 202
  • [9] HOW VALID IS DISEASE-FREE SURVIVAL AS AN ENDPOINT IN ADJUVANT TRIALS
    CARTER, SK
    CONTROLLED CLINICAL TRIALS, 1980, 1 (02): : 177 - 178
  • [10] A meta-analysis of randomized, controlled trials in metastatic melanoma establishes progression-free survival as a surrogate for overall survival
    Flaherty, K. T.
    Lee, S. J.
    Dummer, R.
    Hauschild, A.
    Hennig, M.
    Long, G. V.
    Lorigan, P.
    Robert, C.
    Schadendorf, D.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S856 - S856
12345